Type of Cancer
Breast Oncology
Phase
Division (Location)
Study ID
NCT#
Brief Description
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF ASPIRIN AS ADJUVANT THERAPY FOR NODE POSTIVE HER2 NEGATIVE BREAST CANCER: THE ABC TRIAL
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.